Two gopher snakes (Pitophis melanoleucus catenifer) each were given 5 mg/kg body weight of gentamicin every 72 hours (group 1); two snakes each were given 5 rug/kg/day (group 2). Doses for both groups were given over a 2-week period. After the second week, the dose for one snake in each group was increased to 50 rug/kg/day for 2 more weeks and then discontinued. Weekly renal biopsies taken from snakes in group 1 showed no abnormalities by light microscopy during and at the completion of the experiment. Snakes in group 2 had cloudy swelling of the proximal tubules at 2 and 4 weeks after the gentamicin was administered.
Gentamicin is an antibiotic aminoglycoside derivative of Micromonospora purpurea with high activity against gram-negative bacteria. There is evidence that gentamicin can be nephrotoxic in man [7, 24] , rabbits [8] , dogs [4] , squirrel monkeys [10] , and rats [6, 9, 12, 22] . Renal tubular changes ranging from reversible degeneration to necrosis with azotemia and death are reported in rats. The effects are dose related and strain dependent [12] .
Gentamicin is available commercially (Gentocin, Schering, Kenilworth, N. J.) for parenteral use in dogs and cats and intrauterine administration in horses. The recommended parenteral dose is 4.4 mg/kg, twice the first day, then once a day thereafter.
For the past several years reptiles with infections caused by Aeromonas hydrophila, Pseudomonas, and other gram-negative bacteria [15, 17] have been treated with gentamicin at the National Zoological Park and the Baltimore Zoo. Reptiles treated according to dose schedules recommended for mammals had a high incidence of acute renal failure and gout. Recently, a similar association was made with gentamicin and visceral gout in two boid snakes treated for pneumonia with doses recommended for dogs and cats [II] . Because of these apparent untoward effects, a study to determine safe therapeutic dosages of gentamicin in poikilotherms was made in adult gopher snakes (Pitophis melanoleucus catenifer). Plasma concentrations and the biologic half-life of gentamicin were determined by microbiological assay [21] and correlated with renal biopsies.
Our study is based on sequential renal biopsies taken during various regimens and on necropsies at the end of the experiments. Details of other parts of our study are reported elsewhere [5] .
Materials and Methods
Five gopher snakes (Pitophis melanoleucus catenifer) were obtained from a commercial source and housed in IO-gallon aquarium tanks at 24°C for at least I month before the experiment. Sexes were randomly distributed. The snakes were 77 to 116 centimeters long and weighed 145 to 325 grams. All were in apparent good health and were fed whole mice weekly; water was available ad libitum.
The snakes were divided into two groups (groups I and 2) of two snakes each. The fifth snake was the control. Snakes in group I were given gentamicin at 5 mg/kg every 72 hours; snakes in group 2 were given 5 rug/kg/day. The control received physiological saline daily. Doses for each group and the control were given over a 2-week period. After the second week, the dose for one snake in each group was increased to 50 rug/kg/day for 2 more weeks and then discontinued. The remaining snakes' doses were continued for 2 more weeks. The gentamicin was administered subcutaneously to the hand-held snakes with a microliter syringe.
Renal biopsies were taken from all snakes before treatment and at weekly intervals beginning I week after the first dose was given. Biopsies were taken just before the succeeding dose of gentamicin. The last biopsy was done I week after the final dose was given.
For renal biopsies all snakes were anesthetized with halothane (Fluothane, Ayerst Laboratories, New York), nitrous oxide and oxygen. A small mid-ventral incision was made over the genitourinary organs. The location of the kidneys was determined from previously autopsied gopher snakes by the following method. The distance from the vent to just behind the head was measured. The center of the kidneys was found to be at a point 15% of this measured distance anterior to the vent. Blood samples (0.5 milliliters) were obtained from the exposed posterior vena cava for gentamicin determinations (5] . A small piece (about 3 mm") of kidney was surgically removed. One part was placed in 10% buffered formalin and the other in absolute ethyl alcohol. The surgical gap in the kidney was filled with Surgicel" (Johnson's Professional Products, New Brunswick, N.J.) to control hemorrhage; the incision was closed with 000 surgical gut mattress sutures.
Immediately after the last renal biopsy, each snake was given an overdose of halothane and a necropsy was done. Specimens from most organs were placed in 10% buffered formalin and thin slices of kidney, liver, spleen and pericardium were put in absolute ethyl alcohol. All tissues were embedded in paraffin, sectioned at 5 micrometers, and stained with hematoxylin and eosin (HE). Specimens fixed in absolute alcohol also were stained with the Burtner-Lillie modification of the Gomori stain for uric acid (19] .
The nephron of the metanephric reptilian kidney [3, 13, 25] 
Kesuns
Biopsy specimens of the kidneys serially taken at weekly intervals from snakes in group I were normal. Proximal tubular cells from snakes in group 2 had mild to moderate swelling and granular cytoplasm ( fig. 4 ). These changes were seen 2 weeks after the first injection of gentamicin and similar lesions were seen in kidneys examined on the 4th week after the first injection. Cloudy swelling was not evident in any biopsies taken before treatment or in the tubules of control snakes ( fig. 2 ). There were small clear vacuoles in the cytoplasm of the proximal tubules of the treated snakes and control.
Two weeks after the two snakes were given 50 rug/kg/day, there was swelling of the proximal tubular cells. Cytoplasm formed eosinophilic clumps and there was hydropic degeneration ( fig. 5 ). One week after the high dose was discontinued, many of the proximal tubules were necrotic. In some areas only eosinophilic debris and karyorrhectic nuclear remnants were evident inside the basement membranes of the preexisting tubules ( fig. 6, 7) . Within some of the necrotic tubules was blue-gray Fig. 4 : Renal biopsy from gopher snake given 5 mg/kg gentamicin daily for 2 weeks. Proximal tubules, cloudy swelling. Fig.5 : Renal biopsy from gopher snake given 50 mg/kg/day of gentamicin for 2 weeks. Proximal tubule, hydropic degeneration; distal tubules normal (arrows). Part of sexual segment, Upper right. 111 3 fibrillar material that radiated from the center and was surrounded by heterophils ( fig. 8, 9 ). The fibrillar material stained positively for urates. Gross lesions were limited to snakes that received 50 rug/kg/day of gentamicin. These snakes had chalky-white deposits, mainly in the pericardium and serosal membranes of the abdominal viscera. There were also chalky-white foci I to 5 millimeters in diameter in the kidneys ( fig. 10 ), liver, spleen and lungs. Microscopically, the white deposits and foci were gouty tophi ( fig. 11, 12 ). With the exception of lesions described for the renal biopsies, there were no significant microscopic changes in the other treated groups of snakes or the control.
Discussion
The biologic half-life (tV2) of gentamicin in snakes is 82 hours [5] . In man and dogs the tV2 is between 2 and 3 hours [14, 18] . The prolonged tV2 of gentamicin in snakes apparently allows toxic accumulations when the gentamicin is given daily. In snakes given 5 rag/kg/day (therapeutic for mammals), gentamicin concentrations were up to seven times [5] the 8 to 12 mg/rnl recommended as peak plasma amounts for man [16] .
These findings correlated with the sequential renal biopsies that showed no significant changes with 5 mg/kg of gentamicin given every 72 hours but cloudy swelling of proximal tubules when the same dose of the antibiotic was given daily for 2 weeks. Frank tubular necrosis was not seen until after doses were increased to 50 mg/kg/day for 2 weeks. This may occur with lower doses of gentamicin in snakes with systemic bacterial diseases because these diseases often are accompanied by dehydration, toxemia and decreased nutritional states that could amplify the nephrotoxic effect of gentamicin.
The margin of safety for gentamicin in mammals may not be as wide as thought [7, 12] . Recent ultrastructural studies indicate that nephrotoxic changes occur in the proximal tubules of rats given doses of gentamicin considerably lower than those needed to produce toxic changes seen by light microscopy [22] . Although electron microscopy was not done in our study, it was concluded that in snakes (and perhaps other reptiles), gentamicin should be administered every 72 hours rather than daily and that a prolonged course of therapy be avoided [5] .
The production of visceral gout in our snakes given 50 rug/kg/day is attributed to the severe tubular necrosis. Natural cases of gout with hyperuricemia have been associated with other forms of renal failure, diet and dehydration in snakes [I, 23] and birds [2] . Mechanisms for these forms of gout are not clear. The gout produced with high amounts of gentamicin in our study appears to be the result of reduced renal clearance of uric acid caused by destruction of the proximal tubules and loss of their secretory function. In some cases this caused elevated serum uric acid of 180 mg/dl or greater (normal 2 to 5 mg/dl) [20] , which apparently predisposed the snake to gout. The threshold for uric acid and exact mechanism of formation of tophi have not been studied in reptiles.
Although gout has been produced in birds by dietary manipulation [2] and in Fig.8 : Kidney from gopher snake I week after given 50 mg/kg/day of gentamicin for 2 weeks. Necrotic proximal tubules. Gouty tophus, lower right. Fig.9 : Higher magnification of gouty tophus from figure 8. Urates form radial fibrillar structures surrounded by heterophilic inflammatory cells (arrows). Fig. 10 : Gross lesions from gopher snake given toxic doses of gentamicin. Kidney with gouty tophi. White streaks are urates accumulated within collecting tubules. Fig. 11 : Gouty tophus within pericardium from snake in figure 10 . Black needle-like urate crystals. Absolute alcohol fixation. Gomori uric acid stain, Burtner-Lillie modification. Fig. 12 : Liver from gopher snake in figure 10 . Gouty tophi in capsule and within parenchyma. Absolute alcohol fixation. Gomori uric acid stain, Burtner-Lillie modification. alligators by the intraperitoneal injection of certain amino acids [I], this is the first report in which this metabolic disease has been produced in snakes by injury to renal proximal tubules. This system could be used as a model to study gout in reptiles.
